Skip to main content
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1975 Nov;56(5):1139–1148. doi: 10.1172/JCI108189

Heme synthetase deficiency in human protoporphyria. Demonstration of the defect in liver and cultured skin fibroblasts.

H L Bonkowsky, J R Bloomer, P S Ebert, M J Mahoney
PMCID: PMC301976  PMID: 1184741

Abstract

The final step in heme biosynthesis is chelation of porphyrin with Fe++ catalyzed by the mitochondrial enzyme heme synthetase. We have employed a sensitive radiochemical assay for this enzyme, using 59Fe and deuteroporphyrin or protoporphyrin as substrates. In this method iron is maintained in the ferrous state, oxygen is excluded from the incubation system, and labeled heme product is extracted into ethyl acetate. This assay has been used to measure the activity of heme synthetase in homogenates of liver, obtained by needle biopsy, and in sonicates of human skin fibroblasts, cultured in vitro. In addition, activity of the first enzyme of the heme synthetic pathway, delta-aminolevulinic acid synthetase, has been measured in fibroblast lysates. Lysates of fibroblasts from eight patients with protoporphyria had activities of delta-aminolevulinic acid synthetase which did not differ significantly from those of eight normal fibroblast lines, whereas activity of heme synthetase, with either deuteroporphyrin or protoporphyrin as substrate, was markedly decreased in sonicates of skin fibroblasts from these patients, the mean being 8% of control with deuteroporphyrin and 14% with protoporphyrin as substrate. In homogenates of liver from five patients with protoporphyria, activity of heme synthetase was also significantly less than that found in six patients without prophyria, the mean being 13% of control with protoporphyrin as substrate. These results provide evidence that decreased activity of heme synthetase is the basic defect in the heme synthetic pathway in protoporphyria. This deficiency is probably responsible for protoporphyrin accumulation and hence the biochemical and clinical features observed in protoporphyria.

Full text

PDF
1139

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barnes H. D., Hurworth E., Millar J. H. Erythropoietic porphyrin hepatitis. J Clin Pathol. 1968 Mar;21(2):157–159. doi: 10.1136/jcp.21.2.157. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bonkowsky H. L., Tschudy D. P., Weinbach E. C., Ebert P. S., Doherty J. M. Porphyrin synthesis and mitochondrial respiration in acute intermittent porphyria: studies using cultured human fibroblasts. J Lab Clin Med. 1975 Jan;85(1):93–102. [PubMed] [Google Scholar]
  3. Bottomley S. S. Characterization and measurement of heme synthetase in normal human bone marrow. Blood. 1968 Mar;31(3):314–322. [PubMed] [Google Scholar]
  4. Bottomley S. S., Tanaka M., Everett M. A. Diminished erythroid ferrochelatase activity in protoporphyria. J Lab Clin Med. 1975 Jul;86(1):126–131. [PubMed] [Google Scholar]
  5. Clark K. G., Nicholson D. C. Erythrocyte protoporphyrin and iron uptake in erythropoietic protoporphyria. Clin Sci. 1971 Oct;41(4):363–370. doi: 10.1042/cs0410363. [DOI] [PubMed] [Google Scholar]
  6. Cripps D. J., MacEachern W. N. Hepatic and erythropoietic protoporphyria. Delta-aminolevulinic acid synthetase, fluorescence, and microfluorospectrophotometric study. Arch Pathol. 1971 Jun;91(6):497–505. [PubMed] [Google Scholar]
  7. Cripps D. J., Scheuer P. J. Hepatobiliary changes in erythropoietic protoporphyria. Arch Pathol. 1965 Nov;80(5):500–508. [PubMed] [Google Scholar]
  8. Donaldson E. M., McCall A. J., Magnus I. A., Simpson J. R., Caldwell R. A., Hargreaves T. Erythropoietic protoporphyria: two deaths from hepatic cirrhosis. Br J Dermatol. 1971 Jan;84(1):14–24. doi: 10.1111/j.1365-2133.1971.tb14191.x. [DOI] [PubMed] [Google Scholar]
  9. Dowdle E. B., Mustard P., Eales L. Delta-aminolaevulinic acid synthetase activity in normal and porphyric human livers. S Afr Med J. 1967 Nov 4;41(42):1093–1096. [PubMed] [Google Scholar]
  10. Ebert P. S., Pearson G. R. Correlation of C-type virus (WF-1) production and heme synthesis in a rat fibroblastic cell line. Proc Soc Exp Biol Med. 1974 Jan;145(1):298–301. doi: 10.3181/00379727-145-37797. [DOI] [PubMed] [Google Scholar]
  11. Kassner R. J., Walchak H. Heme formation from Fe(II) and porphyrin in the absence of ferrochelatase activity. Biochim Biophys Acta. 1973 Apr 28;304(2):294–303. doi: 10.1016/0304-4165(73)90247-x. [DOI] [PubMed] [Google Scholar]
  12. Klatskin G., Bloomer J. R. Birefringence of hepatic pigment deposits in erythropoietic protoporphyria. Specificity of polarization microscopy in the identification of hepatic protoporphyrin deposits. Gastroenterology. 1974 Aug;67(2):294–302. [PubMed] [Google Scholar]
  13. LABBE R. F., HUBBARD N., CAUGHEY W. S. Porphyrin specificity of ferro:protoporphyrin chelatase from rat liver. Biochemistry. 1963 Mar-Apr;2:372–374. doi: 10.1021/bi00902a033. [DOI] [PubMed] [Google Scholar]
  14. LABBE R. F., HUBBARD N. Preparation and properties of the iron-protoporphyrin chelating enzyme. Biochim Biophys Acta. 1960 Jul 1;41:185–191. doi: 10.1016/0006-3002(60)90001-9. [DOI] [PubMed] [Google Scholar]
  15. LANGHOF H., MUELLER H., RIETSCHEL L. [Studies on familial, protoporphyrinemic light urticaria]. Arch Klin Exp Dermatol. 1961;212:506–518. [PubMed] [Google Scholar]
  16. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  17. MAGNUS I. A., JARRETT A., PRANKERD T. A., RIMINGTON C. Erythropoietic protoporphyria. A new porphyria syndrome with solar urticaria due to protoporphyrinaemia. Lancet. 1961 Aug 26;2(7200):448–451. doi: 10.1016/s0140-6736(61)92427-8. [DOI] [PubMed] [Google Scholar]
  18. Manyan D. R., Arimura G. K., Yunis A. A. Chloramphenicol-induced erythroid suppression and bone marrow ferrochelatase activity in dogs. J Lab Clin Med. 1972 Jan;79(1):137–144. [PubMed] [Google Scholar]
  19. Marver H. S., Tschudy D. P., Perlroth M. G., Collins A. Delta-aminolevulinic acid synthetase. I. Studies in liver homogenates. J Biol Chem. 1966 Jun 25;241(12):2803–2809. [PubMed] [Google Scholar]
  20. McIntyre N., Pearson A. J., Allan D. J., Craske S., West G. M., Moore M. R., Beattie A. D., Paxton J., Goldberg A. Hepatic delta-aminolaevulinic acid synthetase in an attack of hereditary coproporphyria and during remission. Lancet. 1971 Mar 20;1(7699):560–564. doi: 10.1016/s0140-6736(71)91161-5. [DOI] [PubMed] [Google Scholar]
  21. Meyer U. A. Intermittent acute porphyria. Clinical and biochemical studies of disordered heme biosynthesis. Enzyme. 1973;16(1):334–342. [PubMed] [Google Scholar]
  22. Miyagi K., Cardinal R., Bossenmaier I., Watson C. J. The serum porphobilinogen and hepatic porphobilinogen deaminase in normal and porphyric individuals. J Lab Clin Med. 1971 Nov;78(5):683–695. [PubMed] [Google Scholar]
  23. NISHIDA G., LABBE R. F. Heme biosynthesis; on the incorporation of iron into protoporphyrin. Biochim Biophys Acta. 1959 Feb;31(2):519–524. doi: 10.1016/0006-3002(59)90028-9. [DOI] [PubMed] [Google Scholar]
  24. PORRA R. J., JONES O. T. Studies on ferrochelatase. 1. Assay and properties of ferrochelatase from a pig-liver mitochondrial extract. Biochem J. 1963 Apr;87:181–185. doi: 10.1042/bj0870181. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. PORRA R. J., JONES O. T. Studies on ferrochelatase. 2. An in vestigation of the role offerrochelatase in the biosynthesis of various haem prosthetic groups. Biochem J. 1963 Apr;87:186–192. doi: 10.1042/bj0870186. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. PORTER F. S. CONGENITAL ERYTHROPOIETIC PROTOPORPHYRIA. II. AN EXPERIMENTAL STUDY. Blood. 1963 Nov;22:532–544. [PubMed] [Google Scholar]
  27. PORTER F. S., LOWE B. A. CONGENITAL ERYTHROPOIETIC PROTOPORPHYRIA. I. CASE REPORTS, CLINICAL STUDIES AND PORPHYRIN ANALYSES IN TWO BROTHERS. Blood. 1963 Nov;22:521–531. [PubMed] [Google Scholar]
  28. Pimstone N. R., Blekkenhorst G., Eales L. Enzymatic defects in hepatic porphyria. Preliminary observations in patients with porphyria cutanea tarda and variegate porphyria. Enzyme. 1973;16(1):354–366. [PubMed] [Google Scholar]
  29. RICHMOND J. E., ALTMAN K. I., SALOMON K. Further studies on the biosynthesis of hemin in bone marrow preparations. J Biol Chem. 1954 Dec;211(2):981–988. [PubMed] [Google Scholar]
  30. Sassa S., Granick S., Bickers D. R., Bradlow H. L., Kappas A. A microassay for uroporphyrinogen I synthase, one of three abnormal enzyme activities in acute intermittent porphyria, and its application to the study of the genetics of this disease. Proc Natl Acad Sci U S A. 1974 Mar;71(3):732–736. doi: 10.1073/pnas.71.3.732. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Scholnick P., Marver H. S., Schmid R. Erythropoietic protoporphyria: evidence for multiple sites of excess protoporphyrin formation. J Clin Invest. 1971 Jan;50(1):203–207. doi: 10.1172/JCI106474. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Schwartz S., Johnson J. A., Stephenson B. D., Anderson A. S., Edmondson P. R., Fusaro R. M. Erythropoietic defects in protoporphyria: a study of factors involved in labelling of porphyrins and bile pigments from ALA- 3 H and glycine- 14 C. J Lab Clin Med. 1971 Sep;78(3):411–434. [PubMed] [Google Scholar]
  33. Scott A. J., Ansford A. J., Webster B. H., Stringer H. C. Erythropoietic protoporphyria with features of a sideroblastic anaemia terminating in liver failure. Am J Med. 1973 Feb;54(2):251–259. doi: 10.1016/0002-9343(73)90230-1. [DOI] [PubMed] [Google Scholar]
  34. Strand L. J., Felsher B. F., Redeker A. G., Marver H. S. Heme biosynthesis in intermittent acute prophyria: decreased hepatic conversion of porphobilinogen to porphyrins and increased delta aminolevulinic acid synthetase activity. Proc Natl Acad Sci U S A. 1970 Nov;67(3):1315–1320. doi: 10.1073/pnas.67.3.1315. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Tenhunen R., Marver H. S., Schmid R. Microsomal heme oxygenase. Characterization of the enzyme. J Biol Chem. 1969 Dec 10;244(23):6388–6394. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES